UPMC CARLISLE — History
CCN 390058 | 3-year financial timeline | COVID resilience: 67/100
🛡️ Public data only — no PHI permitted on this instance.
$165M
Latest Revenue (FY2022)
+8.4%
Revenue CAGR (3yr)
19.5%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $140M | $42M | $165M | +292.5% | +8.4% |
| Operating Expenses | $113M | $131M | $133M | +1.4% | +8.4% |
| Operating Margin | 19.4% | -100.0% | 19.5% | +119.5% | +0.3% |
| Net Income | $27M | $-89M | $32M | +136.1% | +8.7% |
| Licensed Beds | 66 | 68 | 72 | +5.9% | +4.4% |
| Total Patient Days | 19,904 | 22,563 | 18,861 | -16.4% | -2.7% |
| Medicare Day % | 36% | 33% | 32% | -3.0% | -5.8% |
| Medicaid Day % | 1% | 3% | 2% | -45.5% | +22.8% |
COVID Impact & Recovery
Resilience Score: 67/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +17.6% ($140M → $165M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▶ Stable
Beds▲ Growing
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+8.4%
This Hospital
+7.6%
State Avg
Latest Margin
19.5%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $177M | 19.5% |
| FY2024 (proj) | $190M | 19.6% |
| FY2025 (proj) | $202M | 19.6% |